Lunai Bioworks Inc (RENB) Live Share Price, Invest From India

Lunai Bioworks Inc Stock Performance

as on October 1, 2025 at 6:59 am IST

Day's Low
Day's High
$1.13
Day's Price Range
$1.43
$1.41
19.86%
Downside
1.42%
Upside
52 Week's Low
52 Week's High
$0.12
52-Week Price Range
$0.45
$1.41
91.39%
Downside
-68.11%
Upside

Lunai Bioworks Inc share price movements today

Previous Close: $1.27
Open: $1.24
Volume: 905.0K
Day's Low - High: $1.13 - $1.43
52 Week Low - High: $0.12 - $0.45

Lunai Bioworks Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Lunai Bioworks Inc Stock Fundamentals & Key Indicators

Check Lunai Bioworks Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Lunai Bioworks Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lunai Bioworks Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Lunai Bioworks Inc	NA	$-	NA	NA	0.00%	NA
BeiGene, Ltd.	NA	$31.1B	NA	67.88	8.94%	NA
Alnylam Pharmaceuticals Inc	BUY	$39.5B	114.85%	74.09	12.55%	NA
Vertex Pharmaceuticals Inc	BUY	$111.0B	114.72%	25.98	35.51%	NA
Regeneron Pharmaceuticals Inc	BUY	$65.8B	23.7%	15.34	29.65%	0.5599999999999999%

Lunai Bioworks Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	0	-	-	-
Gross Profit	0	0	0	0	-	0	0	0	0	-
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-4	-23	-9	-4	-58	-17	-44	-7	0	-126
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-24365.42%	0.00%	0.00%	0.00%

Lunai Bioworks Inc Annual Profit & Loss

All numbers in Millions USD

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	0	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-1	-2	-6	-18	-11	-26	-113	-39	-80	-80
Net Profit Margin	-4057.24%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in Lunai Bioworks Inc

Funds	Holdings
BlackRock Inc	1.17%
Qube Research & Technologies	0.1%
Point72 Asia (Singapore) Pte. Ltd	0.02%
Cubist Systematic Strategies, LLC	0.01%
Jain Global LLC	0.05%

See all

Insights on Lunai Bioworks Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.1% return, outperforming this stock by 134.6%
NO EFFECT
Against Peers
In the last 3 years, Beone Medicines Ltd has given 123.6% return, outperforming this stock by 216.6%
NEGATIVE IMPACT
Price Dip
In the last 7 days, RENB stock has moved down by -26.7%

About Lunai Bioworks Inc

Lunai Bioworks, Inc., formerly Renovaro Inc., is focused on AI-powered biodefense, drug discovery and advanced diagnostics. The Company is engaged in harnessing advanced computational biology and AI/machine learning to accelerate drug discovery, diagnostics and strengthen biosecurity capabilities. From high-resolution phenotyping to predictive disease modeling, the Company is pioneering a new era of precision diagnostics-where early detection, patient stratification, and therapeutic targeting converge into a single, adaptive platform. These are designed to transform clinical decision-making, reduce time-to-treatment, and unlock previously inaccessible insights from biological data. Its proprietary platforms in translational analytics, in vivo modeling, and machine vision-accelerating biomarker discovery and therapeutic development in precision neurology and infectious disease.

Organisation	Lunai Bioworks Inc
E-voting on shares	Click here to vote

FAQs

What is Lunai Bioworks Inc share price today?

Lunai Bioworks Inc share price today is $1.41 as on October 1, 2025 at 1:29 am IST at the close of the market. Lunai Bioworks Inc share today touched a day high of $1.43 and a low of $1.13.

What is the 52 week high and 52 week low for Lunai Bioworks Inc share?

Lunai Bioworks Inc share touched a 52 week high of $0.45 on June 3, 2025 and a 52 week low of $0.12 on September 29, 2025. Lunai Bioworks Inc stock price today i.e. October 1, 2025 at 1:29 am IST is closed at $1.41,which is -213.61% down from its 52 week high and 1061.45% up from its 52 week low.

How to invest in Lunai Bioworks Inc Stock (RENB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lunai Bioworks Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lunai Bioworks Inc Shares that will get you 1.0638 shares as per Lunai Bioworks Inc share price of $1.41 per share as on October 1, 2025 at 1:29 am IST.

What is the minimum amount required to buy Lunai Bioworks Inc Stock (RENB) from India?

Indian investors can start investing in Lunai Bioworks Inc (RENB) shares with as little as ₹94.99 or $1 (as of May 31, 2026 at 9:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.90 in Lunai Bioworks Inc stock (as per the Rupee-Dollar exchange rate as on May 31, 2026 at 9:39 pm IST). Based on Lunai Bioworks Inc share’s latest price of $1.41 as on October 1, 2025 at 1:29 am IST, you will get 7.0922 shares of Lunai Bioworks Inc. Learn more about fractional shares .